(Health-NewsWire.Net, August 03, 2016 ) The report "Atrial Fibrillation Surgery Market by Procedure (Catheter Ablation, Surgical Ablation/Maze), Product (Catheter Ablation, Surgical Ablation), and Geography (Canada, China, France, Germany, India, Japan, U.S., U.K.) - Global Forecast to 2020", The report provides a detailed overview of the major drivers, restraints and opportunities impacting the atrial fibrillation surgery market along with estimates of revenue and competitive landscape.
Browse 18 market data tables and 73 Slides and in-depth TOC on "Atrial Fibrillation Surgery Market"
http://www.marketsandmarkets.com/Market-Reports/atrial-fibrillation-surgery-market-8998731.html
Early buyers will receive 10% customization on this report.
The report provides a detailed overview of the major drivers, restraints and opportunities impacting the atrial fibrillation surgery market along with estimates of revenue and competitive landscape. The types of atrial fibrillation ablation procedures within the scope of the study include catheter ablation and surgical ablation. The global atrial fibrillation surgery procedures market is expected to grow at a CAGR of 11.9% during the forecast period.
The atrial fibrillation surgery market has immense growth potential from 2015 to 2020. The factors propelling growth in this market include increasing number of people suffering from atrial fibrillation and favorable regulations.
Download PDF Brochure @
http://www.marketsandmarkets.com/pdfdownload.asp?id=8998731
About 4.4% people out of diagnosed atrial fibrillation population are treated using ablation technology in the U.S., Europe, and Japan combined. The atrial fibrillation population treated with ablation is expected to grow with a double digit rate in these regions. The increasing prevalence of atrial fibrillation and advancement in the ablation technologies drive the use of ablation products in the treatment of atrial fibrillation.
The European Society of Cardiology guidelines recommend use of surgical and catheter ablation procedures for the treatment of atrial fibrillation, if anti-arrhythmic drug therapy results are inadequate. Further, guidelines recommend using surgical ablation for the treatment of patients failing catheter ablation.
Get Report Sample @
http://www.marketsandmarkets.com/requestsample.asp?id=8998731
This market is segmented, on the basis of surgical procedures, into catheter ablation and surgical ablation. Catheter ablation procedures hold the maximum share in this market and are expected to grow with the highest CAGR during forecast period of 2015 to 2020.
The geographical segmentation includes North America, Europe, Asia-Pacific and RoW. North America holds the largest share in this market, both in terms of number of procedures and revenue. However, Asia-Pacific is expected to witness the highest growth rate owing to the presence of a large patient population, growing medical tourism, and high focus of global market players on emerging Asia-Pacific countries such as China and India.
The major players in this market include Biosense Webster, Inc., St. Jude Medical, Inc., Medtronic, Inc., Boston Scientific Corporation, Articure, Inc., Cardiofocus, Inc., nContact, Inc., Cardima, Inc. and Biotronik SE & Co.
Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com
MarketsandMarkets
Mr. Rohan
1-888-600-6441
sales@marketsandmarkets.com
Source: EmailWire.Com
|